NantHealth Announces FDA Marketing Authorization of Omics Core?: The Nation’s First Tumor-Normal Mutation Profiling of Overall Tumor Mutational Burden from Whole Exome Sequencing in Solid ...
NantHealth, Inc. (NH)
Last nanthealth, inc. earnings: 11/7 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nanthealth.com
Company Research
Source: Business Wire
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing 19,396 protein-coding genes (whole exome) targeting 39 million base pairs (39 Mb) of the human genome from patient tumor and matched normal sample (tumor-normal), for true determination of overall TMB, rather than the commonly-used formulaic extrapolation of TMB from gene panel sequencing.TMB, the measure of all acquired gene-coding mutations in a tumor genome, is an emerging biomarker predicting response to checkpoint therapy and identifies tumors that may benefit from immunotherapy.Omics Core additionally reports somatic mutations in 468 cancer-relevant genes accurate to 2% allele frequency providing a means to guide physician treatment decisions. CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today reported FDA authorization of Omics Core?, the first wh
Show less
Read more
Impact Snapshot
Event Time:
NH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NH alerts
High impacting NantHealth, Inc. news events
Weekly update
A roundup of the hottest topics